See the latest news and media coverage for Cardinal Health. We track all announcements, press releases, and industry mentions in real time, all in one place.
Healthcare services, products, and supply chain company
cardinalhealth.comLast updated
In short: Cardinal Health secured defense awards, delivered strong FY2026 results and extended its CVS deal through 2032.
The company reaffirmed fiscal 2027 non-GAAP EPS guidance of $12.40 to $12.60 and long-term growth guidance of 12% to 14%. The binding letter of intent covers services until June 2032.
The company announces a proxy statement for its November 12, 2026 annual meeting, highlighting significant revenue growth and board leadership transitions.
The financial report details fourth-quarter results including adjusted SG&A expenses and segment profit margins alongside non-GAAP metric definitions.
The board approved a $0.5158 per share dividend payable on October 15, 2026 to shareholders of record as of October 1.
Cardinal Health is extending its existing distribution agreement with CVS Health, paving the way for it to continue supplying drugs to the healthcare giant's pharmacies...
Cardinal Health, Inc. stock (ISIN US14149Y1082) ended the last completed trading day on the New York Stock Exchange at USD 224.95 on September 18, 2026...
Cardinal Health (NYSE:CAH) CEO Jason Hollar said the company expects fiscal 2027 to extend the broad...
Cardinal Health (NYSE:CAH) CEO Jason Hollar said the company’s fiscal 2026 performance was supported...
Track Cardinal Health and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.
